The antiphospholipid syndrome and atherosclerosis: clue to pathogenesis (Q35216331)

7 August 2017

1 reference

title

The antiphospholipid syndrome and atherosclerosis: clue to pathogenesis (English)

1 reference

antiphospholipid syndrome

7 August 2017

main subject

1 reference

Joan T Merrill

1

1 reference

7 August 2017

publication date

1 October 2003

1 reference

Current Rheumatology Reports

7 August 2017

published in

1 reference

7 August 2017

volume

5

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

401-406

1 reference

Antiphospholipid Antibodies: Proposed Mechanisms of Action

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11926-003-0032-6

Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-003-0032-6

Generation of C-reactive protein and complement components in atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-003-0032-6

Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-003-0032-6

Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-003-0032-6

Autoantibodies to the low density lipoprotein receptor in a subject affected by severe hypercholesterolemia

21 January 2018

1 reference

12 December 2020

The superfamily of C3b/C4b-binding proteins.

1 reference

12 December 2020

Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance

1 reference

12 December 2020

Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S

1 reference

12 December 2020

Human C4-binding protein. I. Isolation and characterization

1 reference

12 December 2020

The epitopes of apolipoprotein A-I define distinct structural domains including a mobile middle region

1 reference

12 December 2020

Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques

1 reference

12 December 2020

Elevated prothrombin and activated protein C resistance in patients with thoracic aortic atheroma

1 reference

12 December 2020

C-reactive protein and atherothrombosis

1 reference

12 December 2020

Complement activation in heart diseases. Role of oxidants

1 reference

12 December 2020

Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus

1 reference

12 December 2020

Inhibition of protein S by autoantibodies in patients with acquired protein S deficiency

1 reference

12 December 2020

Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin

1 reference

12 December 2020

Anti-beta 2 glycoprotein I antibodies in systemic lupus erythematosus: a marker of thrombosis associated with a circulating anticoagulant

1 reference

12 December 2020

Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases

1 reference

12 December 2020

Immunization with short peptides from the sequence of the systemic lupus erythematosus-associated 60-kDa Ro autoantigen results in anti-Ro ribonucleoprotein autoimmunity

1 reference

12 December 2020

Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation

1 reference

12 December 2020

Transient anticardiolipin antibodies, functional protein S deficiency, and deep vein thrombosis

1 reference

12 December 2020

Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I

1 reference

12 December 2020

Apolipoprotein A-I structure and lipid properties in homogeneous, reconstituted spherical and discoidal high density lipoproteins

1 reference

12 December 2020

Atherogenic autoantigen: oxidized LDL complexes with beta2-glycoprotein I.

1 reference

12 December 2020

Localization of two epitopes of apolipoprotein A-I that are exposed on human high density lipoproteins using monoclonal antibodies and synthetic peptides.

1 reference

12 December 2020

Natural autoantibody against apolipoprotein A-I. Detection and characterization of the monoclonal antibody established from normal unimmunized BALB/c mice

1 reference

12 December 2020

CD40 co-stimulatory molecule expression by dendritic cells in primary atherosclerotic lesions in carotid arteries and in stenotic saphenous vein coronary artery grafts

1 reference

12 December 2020

Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen

1 reference

12 December 2020

Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?

1 reference

12 December 2020

Antibodies against platelet-activating factor in patients with antiphospholipid antibodies

1 reference

12 December 2020

Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes

1 reference

12 December 2020

Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein

1 reference

12 December 2020

The conformation of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. 13C NMR studies of lysine ionization behavior

1 reference

12 December 2020

An association between plasma free protein s concentration and risk of coronary heart disease in middle-aged men.

1 reference

12 December 2020

Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome

1 reference

12 December 2020

Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate lecithin cholesterol acyl transferase

1 reference

12 December 2020

Selection of a gene for apolipoprotein A1 using autoantibodies from a patient with systemic lupus erythematosus

1 reference

12 December 2020

An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity--a mechanism for thrombosis

1 reference

12 December 2020

Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation

1 reference

12 December 2020

Complement activation in hypercholesterolemia

1 reference

12 December 2020

The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis.

1 reference

12 December 2020

Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus

1 reference

12 December 2020

Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant

1 reference

12 December 2020

Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs

1 reference

12 December 2020

Immune complex hyperlipidemia induced by an apolipoprotein-reactive immunoglobulin A paraprotein from a patient with multiple myeloma. Characterization of this immunoglobulin

1 reference

12 December 2020

C4b-Binding Protein, a Regulatory Component of the Classical Pathway of Complement, Is an Acute-Phase Protein and Is Elevated in Systemic Lupus Erythematosus

1 reference

12 December 2020

Autoantibodies to the protein core of vascular basement membrane heparan sulfate proteoglycan in systemic lupus erythematosus

1 reference

12 December 2020

Protein C, protein S and C4b-binding protein in severe infection and septic shock

1 reference

12 December 2020

Inhibitory activity of anti-beta 2-glycoprotein I antibody on factor Va degradation by activated-protein C and its cofactor protein S

1 reference

12 December 2020

Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus

1 reference

12 December 2020

Differential effects of lecithin and cholesterol on the immunoreactivity and conformation of apolipoprotein A-I in high density lipoproteins

1 reference

12 December 2020

Acquired protein S deficiency

1 reference

12 December 2020

The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low levels of free protein S

1 reference

12 December 2020

Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies

1 reference

12 December 2020

The Association of Anticoagulant Protein Concentrations with Acute Myocardial Infarction in the Thromholysis in Myocardial Infarction Phase II (TIMI II) Trial.

1 reference

12 December 2020

Non beta 2-glycoprotein I cofactors for antiphospholipid antibodies

1 reference

12 December 2020

Natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associates with recent history of venous thromboses, antiphospholipid antibodies, and the antiphospholipid syndrome

1 reference

12 December 2020

Fibrinolytic treatment in primary antiphospholipid syndrome

1 reference

12 December 2020

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss

1 reference

12 December 2020

Cutaneous necrosis resulting from protein S deficiency and increased antiphospholipid antibody in a patient with systemic lupus erythematosus

1 reference

12 December 2020

Anti-idiotypes to oxidized LDL antibodies in intravenous immunoglobulin preparations--possible immunomodulation of atherosclerosis

1 reference

12 December 2020

Cutaneous necrosis associated with the antiphospholipid syndrome and mycosis fungoides

1 reference

12 December 2020

Coumarin-induced skin necrosis associated with acquired protein S deficiency and antiphospholipid antibody syndrome

1 reference

12 December 2020

Modulation of endothelial cell function by antiphospholipid antibodies

1 reference

12 December 2020

Dual antibody reactivity to beta2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome

1 reference

12 December 2020

Immune complexes and IFN-gamma decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages

1 reference

12 December 2020

Role of apolipoprotein A-I in cholesterol transfer between lipoproteins. Evidence for involvement of specific apoA-I domains

1 reference

12 December 2020

Platelets and antiphospholipid antibodies

1 reference

12 December 2020

Protein S levels during the normal menstrual cycle and during estrogen therapy for premature ovarian failure

1 reference

12 December 2020

Antiphospholipid antibodies and thrombosis. A consequence, coincidence, or cause?

1 reference

12 December 2020

Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus

1 reference

12 December 2020

Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception

1 reference

12 December 2020

Anti-beta 2-glycoprotein I autoantibodies and atherosclerosis

1 reference

12 December 2020

Antiphospholipid antibodies and complement activation in patients with cerebral ischemia

1 reference

12 December 2020

Localization of an apolipoprotein A-I epitope critical for activation of lecithin-cholesterol acyltransferase

1 reference

12 December 2020

Kallikrein inhibition and C1-esterase inhibitor levels in patients with the lupus inhibitor

1 reference

12 December 2020

The fibrinolytic response to venous occlusion and the natural anticoagulants in patients with antiphospholipid antibodies both with and without systemic lupus erythematosus

1 reference

12 December 2020

Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity

1 reference

12 December 2020

Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies.

1 reference

12 December 2020

Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients

1 reference

12 December 2020

Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I

1 reference

12 December 2020

Thrombocytopenia corrected by warfarin in antiphospholipid syndrome.

1 reference

12 December 2020

Monoclonal anticardiolipin autoantibodies established from the (New Zealand white x BXSB)F1 mouse model of antiphospholipid syndrome cross-react with oxidized low-density lipoprotein

1 reference

12 December 2020

Lipoprotein(a), other lipoproteins and hemostatic profiles in patients with ischemic stroke: the relation to cardiogenic embolism

1 reference

12 December 2020

Antiphospholipid antibody-dependent C5b-9 formation

1 reference

12 December 2020

Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin

1 reference

12 December 2020

Autoimmune hyperchylomicronemia

1 reference

12 December 2020

Antiphospholipid syndrome: five year follow up

1 reference

12 December 2020

Inflammatory mechanisms in atherosclerosis: from laboratory evidence to clinical application.

1 reference

12 December 2020

10.1007/S11926-003-0032-6

Identifiers

DOI

1 reference

7 August 2017

1 reference